Through the use of FDA adverse event reporting system (FAERS) dataset, this study analyzes the pattern of time-to-event (TTE) for drugs and adverse events, and suggest ways to identify candidate late-
The data used in this study have been curated from multiple publicly available data sources for hypertensive patients, including the FDA’s Adverse Event Reporting System (FAERS), which houses all ADEs